![](/img/cover-not-exists.png)
A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
Mettu, Niharika B., Niedzwiecki, Donna, Rushing, Christel, Nixon, Andrew B., Jia, Jingquan, Haley, Sherri, Honeycutt, Wanda, Hurwitz, Herbert, Bendell, Johanna C., Uronis, HopeLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03805-6
Date:
March, 2019
File:
PDF, 821 KB
english, 2019